Bahram Fathollahi PhD is currently the co-founder and CEO of Acoustic Bio, a spinout from Stanford Genome Technology Center (SGTC) where he was a Visiting Scholar. Before joining the SGTC he was an R&D leader with more than 20 years of experience, including product development, project management, system integration, technical leadership, and establishing strategic partnerships. He has a proven record of building and leading multidisciplinary teams to develop novel integrated microfluidic systems into commercial products (Bioanalyzer, Labchip product line) for pharma research and diagnostic markets. As R&D leader, he has worked in a wide range of technologies, including microchip electrophoresis for analysis of nucleic acids and proteins, cell-based assays on microfluidic chips, microfabrication, consumable development, optical imaging instrumentations, and point-of-care devices for infectious diseases. His current venture, Acoustic Bio, focused on developing a high-throughput organoid screening platform for scaling and accelerating early-stage drug discovery. He received his doctorate in chemical engineering from the University of California, San Diego in 1996.